NRAS and cancer: Among all miRNAs with canonical binding sites on the NRAS 3’UTR (Figure S1 in S1 File), we chose miR-708 as our candidate to perform further molecular and functional analysis since miR-708 is a well-known tumor-suppressive miRNA in various cancer types [33].